课题基金 / 基金详情

THE ALPHA-1C CALCIUM CHANNEL IN MUSCLE

THE ALPHA-1C CALCIUM CHANNEL IN MUSCLE
肌肉中的 ALPHA-1C 钙通道
批准号:
6780376
负责人:
PHILIP T. PALADE
金额:
$27.4万
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-09-27 至 2006-02-28

项目摘要

项目成果

PHILIP T. PALADE的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (Adapted from the applicant's abstract): L-type voltage-gated calcium channels also known as dihydropyridine receptors (DHPRs) are critical for excitation-contraction coupling in both skeletal and cardiac muscle. Each of these muscle types expresses its own isoform of the DHPR. The role of the alpha1C cardiac DHPR in cardiac muscle is unquestionable to both provide the influx of Ca2+ needed to trigger Ca2+ release from intracellular stores as well as to provide a means to refill those stores when they become depleted. In vascular smooth muscle these same channels are the site of action of nearly all Ca2+ channel blockers used therapeutically in the treatment of hypertension and heart disease. Recently certain adult skeletal muscles have been shown to exhibit not only the alpha1S skeletal isoform of the DHPR, but also the alpha1C cardiac isoform, although at lower levels of expression. This grant tests several hypotheses for the role of the cardiac DHPR in adult skeletal muscle. The hypotheses to be tested include refilling of partially depleted intracellular Ca2+ stores, forestalling fatigue, and serving to turn off other genes. Methods will include tension, (Ca2+)i and electrophysiology measurements and measurements of gene expression. The results may suggest additional roles for the alpha1C cardiac DHPRs in the heart as well as in many smooth muscles. This grant also seeks to determine how the steroid hormone dexamethasone, the protein kinase C inhibitor staurosporine, and electrical stimulation regulate the expression of the cardiac DHPR in muscle, and to determine the response elements for the transcription factors involved and for tissue-specific expression within the gene promoter. Additional methods will include traditional assays used for promoter work. These results will enhance understanding of the transcriptional regulation of this extremely important receptor for therapeutic agents in the treatment of hypertension and heart disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MicroRNA to decrease vascular CaV1.2 in hypertension
  • 批准号:
    8389872
  • 项目类别:
  • 资助金额:
    $34.16万
  • 财政年份:
    2010
  • 负责人:
    PHILIP T. PALADE
  • 依托单位:
MicroRNA to decrease vascular CaV1.2 in hypertension
  • 批准号:
    8015274
  • 项目类别:
  • 资助金额:
    $36.25万
  • 财政年份:
    2010
  • 负责人:
    PHILIP T. PALADE
  • 依托单位:
MicroRNA to decrease vascular CaV1.2 in hypertension
  • 批准号:
    8197452
  • 项目类别:
  • 资助金额:
    $35.89万
  • 财政年份:
    2010
  • 负责人:
    PHILIP T. PALADE
  • 依托单位:
MicroRNA to decrease vascular CaV1.2 in hypertension
  • 批准号:
    7785275
  • 项目类别:
  • 资助金额:
    $36.25万
  • 财政年份:
    2010
  • 负责人:
    PHILIP T. PALADE
  • 依托单位:
海外基金